Question

A 22-year-old with non-severe C. difficile infection (first episode) and high risk for recurrence (age <65 but immunocompromised). Which adjunct reduces recurrence when added to standard therapy?

Accepted Answer

Bezlotoxumab infusion during standard therapy

Answer

Probiotics for 30 days

Answer

Cholestyramine

Answer

Loperamide

Answer

Metronidazole taper for 4 weeks

Practice question

A 22-year-old with non-severe C. difficile infection (first episode) and high risk for recurrence (age <65 but immunocompromised). Which adjunct reduces recurrence when added to standard therapy?